These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16563702)

  • 41. Comments on "Optimizing early prediction for antipsychotic response in schizophrenia" by Chang et al.
    Chen L; Kollack-Walker S; Lipkovich IA
    J Clin Psychopharmacol; 2009 Jun; 29(3):311-2. PubMed ID: 19440095
    [No Abstract]   [Full Text] [Related]  

  • 42. Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
    Chang YC; Lane HY
    J Clin Psychopharmacol; 2009 Aug; 29(4):391. PubMed ID: 19593183
    [No Abstract]   [Full Text] [Related]  

  • 43. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
    [No Abstract]   [Full Text] [Related]  

  • 44. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings.
    Opler MG; Yang LH; Caleo S; Alberti P
    BMC Psychiatry; 2007 Jul; 7():35. PubMed ID: 17650312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction: evaluating clinical trial data from schizophrenia research.
    Tamminga CA
    J Clin Psychiatry; 2001; 62 Suppl 9():3-4. PubMed ID: 11379829
    [No Abstract]   [Full Text] [Related]  

  • 46. Piperacetazine vs. thioridazine for the control of schizophrenia in outpatients.
    Rada RT; Donlon PT
    Psychosomatics; 1972; 13(6):373-6. PubMed ID: 4153002
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
    Gazdag G; Tolna J; Bitter I
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quetiapine, an atypical antipsychotic.
    Goren JL; Levin GM
    Pharmacotherapy; 1998; 18(6):1183-94. PubMed ID: 9855315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quetiapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044
    [No Abstract]   [Full Text] [Related]  

  • 50. Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Heuser I; Maier W; Klosterkötter J; Falkai P; Schlösser R; Schmitt A; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ
    Schizophr Res; 2014 Feb; 152(2-3):478-86. PubMed ID: 23643327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When should drug treatment be initiated in schizophrenia?
    Malla AK
    J Psychiatry Neurosci; 1999 Sep; 24(4):363. PubMed ID: 11499428
    [No Abstract]   [Full Text] [Related]  

  • 52. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Daily life of schizophrenic patients "in remission"].
    Leguay D
    Encephale; 2005 Dec; 31 Pt 2():S24-8. PubMed ID: 16462632
    [No Abstract]   [Full Text] [Related]  

  • 54. [What are the representations of remission for the patient?].
    Lançon C
    Encephale; 2005 Dec; 31 Pt 2():S13-4. PubMed ID: 16462628
    [No Abstract]   [Full Text] [Related]  

  • 55. [What are the representations of remission for the psychiatrist?].
    Pascal JC
    Encephale; 2005 Dec; 31 Pt 2():S11-2. PubMed ID: 16462627
    [No Abstract]   [Full Text] [Related]  

  • 56. CATIE findings revisited.
    Davis JM; Leucht S; Glick ID
    Psychiatr Serv; 2009 Jan; 60(1):125-6. PubMed ID: 19114584
    [No Abstract]   [Full Text] [Related]  

  • 57. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):525. PubMed ID: 26375766
    [No Abstract]   [Full Text] [Related]  

  • 58. Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia.
    Leucht S; Kane JM
    J Clin Psychiatry; 2006 Nov; 67(11):1813-4. PubMed ID: 17196063
    [No Abstract]   [Full Text] [Related]  

  • 59. Schizophrenia drug shines in phase III.
    Kingwell K
    Nat Rev Drug Discov; 2022 Oct; 21(10):702. PubMed ID: 36045284
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Maia-de-Oliveira JP; Baker GB; Dursun SM; Hallak JE
    Psychol Med; 2017 Apr; 47(5):981-982. PubMed ID: 27931266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.